Abstract
Two recent trials concluded that the use of oral contraceptives (OC) did not induce flares in lupus patients. We record our experience with OC in patients with stable lupus. Eight patients were enrolled in an open trial. Six received a combined contraceptive pill and two were allocated to the control arm. During a 12 month follow-up, 3 patients in the active arm experienced 4 major flares. One patient died as a result of uncontrolled disease complicated by sepsis. At this point, we abandoned the trial. The 2 patients in the control arm experienced no disease exacerbation during the 7 months of observation. We would urge that patients who are placed on OC be closely monitored.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Petri M, Kim MY, Kalunian KC et al (2005) Combined oral contraception in women with systemic lupus erythematosus. N Engl J Med 353:2550–2558
Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539–2549
Bermas BL (2005) Oral contraceptives in systemic lupus erythematosus—a tough pill to swallow? N Engl J Med 353:2602–2604
Cooper GS, Parks CG, Treadwell EL et al (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11:161–167
Alarcon GS, McGwin G Jr, Petri M et al (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95–101
Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
Austin HA 3rd, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614–619
Ehrenstein MR, Conroy SE, Heath J et al (1995) The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: a rheumatological view. Br J Rheumatol 34:257–260
Petri M, Genovese M, Engle E et al (1991) Definition, incidence and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937–944
Rampone A, Rampone B, Tirabasso S et al (2001) Contraception with the latest estroprostagens in women suffering from systemic lupus erythematosus. Minerva Ginecol 53(1 Suppl 1):75–77
Julkunen HA (1991) Oral contraception in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheum 20:427–433
Jungers P, Dougados M, Pelissier C et al (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25:618–623
Buyon JP, Petri MA, Kim MY et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962
Grimaldi CM, Hill L, Xu X et al (2005) Hormonal modulation of B cell development and repertoire selection. Mol Immunol 42:811–820
Cutolo M (2004) Estrogen metabolites: increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31:419–421
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whitelaw, D.A., Jessop, S.J. Major flares in women with SLE on combined oral contraception. Clin Rheumatol 26, 2163–2165 (2007). https://doi.org/10.1007/s10067-007-0641-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0641-y